Resolvin D1 inhibits the proliferation of lipopolysaccharide‑treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway
Cited by 21
Related Papers
Consensus for HER2 alterations testing in non-small-cell lung cancer
|ESMO Open|2022|110
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
|Journal of Cancer Research and Clinical Oncology|2002|77
Effects of lysophosphatidic acid and its receptors LPA__AMB__frac13; on radiation pneumonitis
|Oncology Reports|2010|20